The flow cytometry myeloid progenitor count: A reproducible parameter for diagnosis and prognosis of myelodysplastic syndromes-Reference-Cited by-同舟云学术

The flow cytometry myeloid progenitor count: A reproducible parameter for diagnosis and prognosis of myelodysplastic syndromes

Published:2021-12-21 Issue: Volume: Page:
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry Part B Clinical

Author:

Johansson Ulrika¹^ORCID,McIver‐Brown Neil²,Cullen Matthew³,Duetz Carolien⁴,Dunlop Alan⁵,Oelschlägel Uta⁶,Psarra Katherina⁷,Subirá Dolores⁸^ORCID,Westers Theresia M.⁹

Affiliation:

1. Haematological Malignancy Diagnostic Service University Hospitals and Weston NHS Foundation Trust Bristol UK

2. Molecular Pathology Department, Royal Bournemouth Hospital University Hospitals Dorset NHS Foundation Trust Bournemouth UK

3. Haematological Malignancy Diagnostic Service St James's University Hospital Leeds UK

4. Department of Haematology Amsterdam University Medical Centres, VU University Medical Center Amsterdam The Netherlands

5. Haematological Malignancy Diagnostic Centre King's College Hospital NHS Foundation Trust London UK

6. Department of Haematology, Medical Clinic and Policlinic I University Hospital of TU Dresden Dresden Germany

7. Department of Immunology and Histocompatibility Evangelismos Hospital Athens Greece

8. Department of Haematology Hospital Universitario de Guadalajara Guadalajara Spain

9. Department of Hematology Amsterdam University Medical Centers, Location VU University Medical Center, Cancer Center Amsterdam Amsterdam The Netherlands

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.22048

Reference42 articles.

1. A novel method to assess bone marrow purity is useful in determining blast percentage by flow cytometry in acute myeloid leukemia and myelodysplasia;Aldawood A.;Annals of Hematology & Oncology,2015

2. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes

3. An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups

4. Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

5. Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells;Leukemia;2024-03-08

2. Diagnosis of erythroid dysplasia by flow cytometry: a review;Expert Review of Hematology;2023-12-02

3. Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms;Clinics in Laboratory Medicine;2023-12

4. Accuracy of Blast Enumeration in Bone Marrow by Cytomorphology, Flow Cytometry Immunophenotyping, and Immunohistochemistry Methods in Patients with Myelodysplastic Neoplasm and Acute Myeloid Leukemia;Istanbul Medical Journal;2023-08-01

5. Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes;Blood;2023-02-01